Skip to content

The optimal timing for endoscopic-assisted intervention in capsule endoscopy and related risk factors affecting transport process

The optimal timing for endoscopic-assisted intervention in capsule endoscopy and related risk factors affecting transport process

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075802
Enrollment
Unknown
Registered
2023-09-15
Start date
2022-12-16
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The problem of transport delay in capsule examination of gastrointestinal diseases

Interventions

A group (T<60% ):N/A
B group (60% = T < 90% ):N/A
C group (T = 90% ):N/A

Sponsors

Renji Hospital, School of Medicine,Shanghai Jiao Tong Univesity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 81 Years

Inclusion criteria

Inclusion criteria: (1)Unexplained gastrointestinal bleeding; (2)Unexplained iron-deficiency anemia; (3)Suspected Crohn's disease or monitoring and guiding the treatment of Crohn's disease; (4)Suspected small intestinal tumor; (5)Monitoring small intestinal polyposis syndrome; (6)Suspected or difficult-to-control malabsorption syndrome, such as celiac disease, etc.; (7)Detecting non-steroidal anti-inflammatory drug-related small intestinal mucosal damage; (8)Clinically needing to exclude small intestinal diseases.

Exclusion criteria

Exclusion criteria: (1)Absolute contraindications: Individuals without surgical options or those who refuse any abdominal surgery (once the capsule becomes lodged, it cannot be removed through surgery); (2)Relative contraindications: ? Known or suspected gastrointestinal obstruction, stenosis, or fistulas; ? Individuals with pacemakers or other implanted electronic devices; ? Those with swallowing disorders; ? Pregnant women.

Design outcomes

Primary

MeasureTime frame
Completion rate;Small bowel transit time;

Secondary

MeasureTime frame
Pylorus transit time;Diagnostic rate of lesions;

Countries

China

Contacts

Public ContactChen Huimin

Renji Hospital , School of Medicine,Shanghai Jiao Tong Univesity

117916829@qq.com+86 21 6838 3112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026